relcovaptan has been researched along with Anesthesia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faghihi, M; Imani, A; Moghimian, M; Nazari, A; Sadr, SS | 1 |
Barthelmebs, M; Cazaubon, C; De Jong, W; Helwig, JJ; Imbs, JL; Loichot, C; Nisato, D | 1 |
2 other study(ies) available for relcovaptan and Anesthesia
Article | Year |
---|---|
The cardioprotective effect of different doses of vasopressin (AVP) against ischemia-reperfusion injuries in the anesthetized rat heart.
Topics: Anesthesia; Animals; Antidiuretic Hormone Receptor Antagonists; Arrhythmias, Cardiac; Blood Pressure; Cardiotonic Agents; Creatine Kinase, MB Form; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Hemodynamics; Indoles; L-Lactate Dehydrogenase; Male; Malondialdehyde; Models, Animal; Myocardial Reperfusion Injury; Pyrrolidines; Rats; Tachycardia, Ventricular; Time Factors; Vasopressins | 2011 |
Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vasopressin-induced renal vasoconstriction in rats.
Topics: Anesthesia; Animals; Antidiuretic Hormone Receptor Antagonists; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Drug Interactions; Hemodynamics; Hormone Antagonists; Indoles; Male; Nitric Oxide; Pyrrolidines; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Renal Agents; Renal Artery; Renal Circulation; Thiopental; Vasoconstriction; Vasodilator Agents; Vasopressins | 2000 |